179 related articles for article (PubMed ID: 23983139)
1. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
[TBL] [Abstract][Full Text] [Related]
2. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug.
Lee KW; Porter CJ; Boyd BJ
J Pharm Sci; 2013 Feb; 102(2):565-78. PubMed ID: 23242691
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
[TBL] [Abstract][Full Text] [Related]
4. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
[TBL] [Abstract][Full Text] [Related]
5. Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles.
Yeap YY; Trevaskis NL; Porter CJ
Pharm Res; 2013 Dec; 30(12):3045-58. PubMed ID: 23793990
[TBL] [Abstract][Full Text] [Related]
6. Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
Porter CJ; Kaukonen AM; Taillardat-Bertschinger A; Boyd BJ; O'Connor JM; Edwards GA; Charman WN
J Pharm Sci; 2004 May; 93(5):1110-21. PubMed ID: 15067688
[TBL] [Abstract][Full Text] [Related]
7. Digestion is a critical element for absorption of cinnarizine from supersaturated lipid-based type I formulations.
Paulus F; Bauer-Brandl A; Stappaerts J; Holm R
Eur J Pharm Sci; 2024 Jan; 192():106634. PubMed ID: 37951315
[TBL] [Abstract][Full Text] [Related]
8. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
9. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.
Larsen AT; Åkesson P; Juréus A; Saaby L; Abu-Rmaileh R; Abrahamsson B; Østergaard J; Müllertz A
Pharm Res; 2013 Dec; 30(12):3101-13. PubMed ID: 23949249
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of poorly soluble basic drugs into enteric microparticles: a novel approach to enhance their oral bioavailability.
Alhnan MA; Murdan S; Basit AW
Int J Pharm; 2011 Sep; 416(1):55-60. PubMed ID: 21679756
[TBL] [Abstract][Full Text] [Related]
12. Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
Yeap YY; Trevaskis NL; Quach T; Tso P; Charman WN; Porter CJ
Mol Pharm; 2013 May; 10(5):1874-89. PubMed ID: 23480483
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
Grove M; Müllertz A; Nielsen JL; Pedersen GP
Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738
[TBL] [Abstract][Full Text] [Related]
14. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
[TBL] [Abstract][Full Text] [Related]
15. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
[TBL] [Abstract][Full Text] [Related]
17. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
18. Digestion behavior, in vitro and in vivo bioavailability of cannabidiol in emulsions stabilized by whey protein-maltodextrin conjugate: Impact of carrier oil.
Wang C; Dong C; Lu Y; Freeman K; Wang C; Guo M
Colloids Surf B Biointerfaces; 2023 Mar; 223():113154. PubMed ID: 36708645
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
Nguyen TH; Hanley T; Porter CJ; Boyd BJ
J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of seocalcitol I: Relating solubility in biorelevant media with oral bioavailability in rats--effect of medium and long chain triglycerides.
Grove M; Pedersen GP; Nielsen JL; Müllertz A
J Pharm Sci; 2005 Aug; 94(8):1830-8. PubMed ID: 15986460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]